Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +17.56%
#2 Fake World Assets Fake World Assets +13.79%
#3 B3 (Base) B3 (Base) +10.99%
#4 OriginTrail OriginTrail +6.62%
#5 Pons Pons +6.30%
#6 Storj Storj +5.13%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +4.89%
#8 Siren Siren +4.48%
#9 Ontology Gas Ontology Gas +4.02%
#10 Audiera Audiera +3.81%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Neonc Technologies Holdings, Inc. Neonc Technologies Holdings, Inc.

Neonc Technologies Holdings, Inc.

NTHI
Rank in Stocks #20827
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical... NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Share Price
$4.67
Last synced: 2026-08-21
Market Cap
$121.10M
Change (1 day)
2.41%
Change (1 year)
-19.76%
Country
US
Trade Neonc Technologies Holdings, Inc. (NTHI)

Category

Healthcare
Revenue for Neonc Technologies Holdings, Inc. (NTHI)
Revenue in Aug 2026 TTM: 0
According to Neonc Technologies Holdings, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Neonc Technologies Holdings, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH